Similar articles for PMID: 15477218

Year	Number of Results
1989	1
1991	1
1997	1
2002	5
2003	6
2004	5
2005	16
2006	15
2007	12
2008	10
2009	7
2010	2
2011	2
2013	1
2014	1
2015	2
2016	1
2017	1
2024	0

1

The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients.

Piccaluga PP, Malagola M, Amabile M, Rondoni M, Paolini S, Pane F, Russo D, Visani G, Baccarani M, Martinelli G. Piccaluga PP, et al. Haematologica. 2004 Oct;89(10):1269-71. Haematologica. 2004. PMID: 15477218

2

Treatment of elderly patients with acute lymphoblastic leukemia--evidence for a benefit of imatinib in BCR-ABL positive patients.

Brandwein JM, Gupta V, Wells RA, Schuh AC, Schimmer AD, Lipton JH, Messner HA, Yi QL, Chun K, Kamel-Reid S, Minden MD. Brandwein JM, et al. Leuk Res. 2005 Dec;29(12):1381-6. doi: 10.1016/j.leukres.2005.04.020. Epub 2005 May 31. Leuk Res. 2005. PMID: 15927253

3

Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate.

Cortes J, Talpaz M, O'Brien S, Jones D, Luthra R, Shan J, Giles F, Faderl S, Verstovsek S, Garcia-Manero G, Rios MB, Kantarjian H. Cortes J, et al. Clin Cancer Res. 2005 May 1;11(9):3425-32. doi: 10.1158/1078-0432.CCR-04-2139. Clin Cancer Res. 2005. PMID: 15867244 Clinical Trial.

4

Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission.

Potenza L, Luppi M, Riva G, Marasca R, Martinelli S, Torelli G. Potenza L, et al. Haematologica. 2005 Sep;90(9):1275-7. Haematologica. 2005. PMID: 16154854 Free article.

5

Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.

Lahaye T, Riehm B, Berger U, Paschka P, Müller MC, Kreil S, Merx K, Schwindel U, Schoch C, Hehlmann R, Hochhaus A. Lahaye T, et al. Cancer. 2005 Apr 15;103(8):1659-69. doi: 10.1002/cncr.20922. Cancer. 2005. PMID: 15747376 Free article. Clinical Trial.

6

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group.

Yanada M, Takeuchi J, Sugiura I, Akiyama H, Usui N, Yagasaki F, Kobayashi T, Ueda Y, Takeuchi M, Miyawaki S, Maruta A, Emi N, Miyazaki Y, Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R; Japan Adult Leukemia Study Group. Yanada M, et al. J Clin Oncol. 2006 Jan 20;24(3):460-6. doi: 10.1200/JCO.2005.03.2177. Epub 2005 Dec 12. J Clin Oncol. 2006. PMID: 16344315 Clinical Trial.

7

[Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].

Zhang GC, Zheng D, Li QH, Li XH, Cai CC, Luo SK, Li J, Peng AH, Tong XZ, Tan EX, Hong WD. Zhang GC, et al. Ai Zheng. 2004 Dec;23(12):1696-9. Ai Zheng. 2004. PMID: 15601563 Chinese.

8

Long-term remission in BCR/ABL-positive AML-M6 patient treated with Imatinib Mesylate.

Pompetti F, Spadano A, Sau A, Mennucci A, Russo R, Catinella V, Franchi PG, Calabrese G, Palka G, Fioritoni G, Iacone A. Pompetti F, et al. Leuk Res. 2007 Apr;31(4):563-7. doi: 10.1016/j.leukres.2006.05.021. Epub 2006 Aug 17. Leuk Res. 2007. PMID: 16916543

9

Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia.

Wernstedt P, Brune M, Andersson PO, Gustavsson B, Stockelberg D, Wadenvik H. Wernstedt P, et al. Bone Marrow Transplant. 2002 Dec;30(12):971-3. doi: 10.1038/sj.bmt.1703760. Bone Marrow Transplant. 2002. PMID: 12476293

10

Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients.

Iacobucci I, Saglio G, Rosti G, Testoni N, Pane F, Amabile M, Poerio A, Soverini S, Bassi S, Cilloni D, Bassan R, Breccia M, Lauria F, Izzo B, Merante S, Frassoni F, Paolini S, Montefusco E, Baccarani M, Martinelli G; GIMEMA Working Party on Chronic Myeloid Leukemia. Iacobucci I, et al. Clin Cancer Res. 2006 May 15;12(10):3037-42. doi: 10.1158/1078-0432.CCR-05-2574. Clin Cancer Res. 2006. PMID: 16707599 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

80 results

Results by year